Pre-Incisional Ketorolac for Patients Undergoing Surgery for Non-Small Cell Lung Cancer and Renal Cell Carcinoma

NCT04495894 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

68

Enrollment

OTHER

Sponsor class

Stopped This study was terminated after interim analyses showed no benefits.

Conditions

Non-small Cell Lung Cancer
Renal Cell Carcinoma

Interventions

DRUG: Preoperative Ketorolac

Sponsor

Emory University